PSEUDOMYXOMA PERITONEI ASSOCIATED WITH OVARIAN MUCINOUS CYSTADENOMA: DIAGNOSTIC CHALLENGES IN DETERMINING THE PRIMARY ORIGIN
Main Article Content
Abstract
Background: Pseudomyxoma peritonei (PMP) is a clinical term referring to diffuse intraperitoneal accumulation of mucin secondary to mucinous neoplasms. It remains a controversial entity with respect to biological behavior and nomenclature. The majority of cases originate from appendiceal mucinous neoplasms. However, when PMP is associated with a morphologically benign ovarian mucinous tumor, determining the primary site becomes a significant diagnostic challenge.
Case presentation: A 32-year-old woman was incidentally found to have a left ovarian mass during a routine prenatal examination. Ultrasound and MRI revealed a large multilocular cystic lesion associated with free intraperitoneal fluid (ORADS 4–5). The patient underwent left oophorectomy, partial right oophorectomy, and appendectomy. Grossly, the tumor was a cystic mass filled with mucinous material. Histologically, it was consistent with mucinous cystadenoma lined by benign-appearing mucinous columnar epithelium. Peritoneal nodules, omentum, and small bowel specimens demonstrated abundant low-cellularity mucin without cytologic atypia. No neoplasm was identified in the appendix.
Conclusion: The final diagnosis was left ovarian mucinous cystadenoma associated with grade 1 pseudomyxoma peritonei. This case raises the question of whether the intraperitoneal mucin originated from a benign ovarian tumor or from an undetected primary lesion elsewhere. Comprehensive histopathological evaluation and a systematic diagnostic approach are essential for determining the origin of the disease.
Keywords
Ovarian mucinous cystadenoma, Pseudomyxoma peritonei
Article Details
References
2. Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017 Aug;33(5):511-519.
3. Murage NW, Ahmed NM, Underwood TJ, et al. The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review. Cancer Cell International. 2023;42:335–359.
4. Norman J. Carr, Cecil TD, Mohamed F, et al.
A consensus for classification and athologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: The results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. American Journal of Surgical Pathology. 2016;40(1):14–26.
5. WHO Classification of Tumours Editorial Board. Digestive System Tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2019.
6. Govaerts K, Chandrakumaran K, Carr NJ, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. European Journal of Surgical Oncology. 2021;47(1):11-35. doi:10.1016/j.ejso.2020.02.012.